Showing results (61-70 of 279) with videos related to
Sort By:
Pageof 28
Urologic Oncology|March 18, 2014
NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladderAaron Potretzke, Luke Hillman, Kelvin Wong, et al.The Journal of Urology|August 12, 2005
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II studyNatasha M Tiffany, Christopher W Ryan, Mark Garzotto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30Erik K Fromme, Kristine M Eilers, Motomi Mori, et al.Cancer Immunology Research|May 6, 2014
Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancerJulie N Graff, Sachin Puri, Carlo B Bifulco, et al.The Journal of Urology|August 8, 2006
Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancerChristopher W Ryan, Dezheng Huo, Laurence M Demers, et al.The Prostate|July 13, 2007
Prostate cancer survival is dependent on season of diagnosisZoya Lagunova, Alina Carmen Porojnicu, Arne Dahlback, et al.The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.Diagnostic Cytopathology|November 13, 2004
Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancerJohn T Vetto, Tomasz M Beer, Nisreen Fidda, et al.Pilot and Feasibility Studies|December 9, 2021
A pilot feasibility study of Exercising Together© during radiation therapy for prostate cancer: a dyadic approach for patients and spousesKerri M Winters-Stone, Karen S Lyons, Tomasz M Beer, et al.American Journal of Clinical Oncology|April 21, 2022
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer: Benefit or Caution?Carl M Post, Jenna M Kahn, Claire B Turina, et al.Pageof 28